Keywords : Blood, blood cell, red blood cell, plasma, white blood cell, blood component, platelet, whole blood
Summary Cerus Corporation (Cerus) is a biomedical products manufacturing company which undertakes the development and commercialization of novel, proprietary products and technologies, intended to make the blood supply safer. The company focuses on the development and commercialization of INTERCEPT Blood System based on its proprietary Helinx technology. Cerus holds the worldwide rights of INTERCEPT for three blood components, namel...
More »
Search ReportLinker
The Largest Collection of Market Research Reports
» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides
From +200,000 authoritative sources
Summary
Cerus Corporation (Cerus) is a biomedical products manufacturing company which undertakes the development and commercialization of novel, proprietary products and technologies, intended to make the blood supply safer. The company focuses on the development and commercialization of INTERCEPT Blood System based on its proprietary Helinx technology. Cerus holds the worldwide rights of INTERCEPT for three blood components, namely, platelets, red blood cells and plasma. The system is designed to target and inactivate blood-borne pathogens, such as viruses, bacteria, and parasites, as well as harmful white blood cells (WBC) included in donated blood components intended for transfusion. It is a pathogen inactivation system that is being marketed in Europe, Russia, the Middle East and selected countries of other regions of the world for the treatment of both platelets and plasma for transfusions and it is also being developed for the treatment of red blood cells. Cerus is headquartered in Concord, California, the US.
Cerus Corporation (CERS) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Blood Supply, Tissue Banking And Transplantation Industry in the United States
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Cerus Corporation, Medical Equipment, Deals By Year, 2007 to YTD 2013 4
Cerus Corporation, Medical Equipment Deals By Type, 2007 to YTD 2013 5
Cerus Corporation, Medical Equipment, Deals By Region, 2007 to YTD 2013 6
Cerus Corporation, Medical Equipment, Deals By Market, 2007 to YTD 2013 7
Cerus Corporation, Medical Equipment, Deals Summary, 2007 to YTD 2013 8
Cerus Corporation, Medical Equipment, Deal Details 9
Partnerships 9
Cerus Enters Into Distribution Agreement With American Red Cross For Intercept Plasma 9
Cerus Enters Into Distribution Agreement With Blood Systems For Intercept Plasma 10
Cerus Enters Into Distribution Agreement With Ilex Biotech 11
Cerus Enters Into Agreement With CSL 12
Cerus Enters Into An Agreement With Grifols 13
Cerus Enters Into Co-Development Agreement With German Red Cross 14
Grifols Signs An Agreement With Cerus 15
Equity Offering 16
Cerus Prices Public Offering Of Common Stock For US$35 Million 16
Cerus Completes Underwritten Public Offering Of US$21 Million 18
Cerus Completes Private Placement Of Units For US$13.2 Million 20
Cerus Corporation - Key Competitors 22
Key Employees 23
Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Apr 30, 2013: Cerus Reports Revenue Of $9.7m In Q1 2013 25
Feb 28, 2013: Cerus Reports Revenue Of $36.7m In 2012 26
Nov 07, 2012: Cerus Reports Revenue Of $8.3m In Q3 2012 27
May 01, 2012: Cerus Reports Revenue Of $8.8m In Q1 2012 28
Feb 28, 2012: Cerus Reports Revenue Of $10.4m In Q4 2011 29
Corporate Communications 29
Jan 09, 2012: Cerus Appoints Andrew Gomperts As Chief Business Officer 29
Product News 30
Apr 24, 2013: Cerus Announces FDA Agreement On Modular PMA Submission Process For Intercept Platelets 30
Dec 13, 2012: Cerus Announces FDA Agreement On Modular PMA Submission Process For Intercept Plasma 31
Dec 04, 2012: Cerus Signs Agreement With Swiss Red Cross For Initial Deployment Of Intercept Blood System For Plasma 31
Sep 11, 2012: Cerus To Partner With American Red Cross And BSI To Commercialize Intercept Plasma For Thrombotic Thrombocytopenic Purpura 32
Sep 04, 2012: Cerus’ South African Distributor Seeks Regulatory Approval For Intercept Blood System 32
Aug 07, 2012: Cerus’ Distributor Signs Agreements For INTERCEPT Blood System In Turkey 33
Apr 30, 2012: Cerus, University Hospitals Of Geneva And Transfusion Service Of Swiss Red Cross Intend To Collaborate On Whole Blood Pathogen Inactivation For Africa 33
Apr 24, 2012: Cerus And NYBC To Collaborate On Development Of New RBC Biologic Product With Improved Uniformity 34
Mar 21, 2012: Cerus Submits IDE Supplement To FDA For Phase III INTERCEPT Red Blood Cell Study 35
Clinical Trials 35
Mar 21, 2012: Cerus Submits IDE Supplement To FDA For Phase III INTERCEPT Red Blood Cell Study 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
Cerus Corporation, Medical Equipment, Key Facts, 2012 1
Cerus Corporation, Medical Equipment, Deals By Year, 2007 to YTD 2013 1
Cerus Corporation, Medical Equipment, Deals By Region, 2007 to YTD 2013 1
Cerus Corporation, Medical Equipment, Deals By Market, 2007 to YTD 2013 1
Cerus Corporation, Medical Equipment, Deals Summary, 2007 to YTD 2013 1
Cerus Corporation, Medical Equipment, Deals By Year, 2007 to YTD 2013 4
Cerus Corporation, Medical Equipment Deals By Type, 2007 to YTD 2013 5
Cerus Corporation, Medical Equipment, Deals By Region, 2007 to YTD 2013 6
Cerus Corporation, Deals By Market, 2007 to YTD 2013 7
Cerus Corporation, Medical Equipment, Deals Summary, 2007 to YTD 2013 8
Cerus Enters Into Distribution Agreement With American Red Cross For Intercept Plasma 9
Cerus Enters Into Distribution Agreement With Blood Systems For Intercept Plasma 10
Cerus Enters Into Distribution Agreement With Ilex Biotech 11
Cerus Enters Into Agreement With CSL 12
Cerus Enters Into An Agreement With Grifols 13
Cerus Enters Into Co-Development Agreement With German Red Cross 14
Grifols Signs An Agreement With Cerus 15
Cerus Prices Public Offering Of Common Stock For US$35 Million 16
Cerus Completes Underwritten Public Offering Of US$21 Million 18
Cerus Completes Private Placement Of Units For US$13.2 Million 20
Cerus Corporation, Key Competitors 22
Cerus Corporation, Key Employees 23
Cerus Corporation, Subsidiaries 24
List of Figures
Cerus Corporation, Medical Equipment, Deals by Type, 2007 to YTD 2013 1
Cerus Corporation, Medical Equipment, Deals By Year, 2007 to YTD 2013 4
Cerus Corporation, Medical Equipment, Deals by Type, 2007 to YTD 2013 5
Cerus Corporation, Medical Equipment, Deals By Region, 2007 to YTD 2013 6
Cerus Corporation, Medical Equipment, Deals by Market, 2007 to YTD 2013 7
